Launching In
Mark your calendar. This is the protocol you've been waiting for.
What PulseLine Will Be
You've heard omega-3s protect your heart. But which ones — EPA or DHA? At what dose? And does the science actually back the marketing claims? PulseLine is a focused, evidence-based protocol that breaks down the cardiovascular research on omega-3 fatty acids. We're building the definitive guide to EPA vs DHA for heart health, triglyceride reduction, and blood pressure management — backed by the REDUCE-IT trial, VITAL study, AHA guidelines, and 40 years of cardiovascular data. No fluff. No affiliate agendas. Just the numbers that matter.
Who It's For
PulseLine is built for anyone navigating the omega-3 maze:
- Men and women with elevated triglycerides (above 150 mg/dL) looking for non-pharmaceutical options
- Anyone on statins wondering if omega-3s add real benefit — and at what dose
- People managing blood pressure who want to understand the EPA evidence for arterial health
- Anyone confused by supplement labels — ethyl esters vs triglyceride form, EPA percentage, oxidation markers
Preview: "EPA vs DHA — The 4g/day Question"
A deep-dive into the REDUCE-IT trial results, why 4 grams of EPA daily reduced cardiovascular events by 25%, and what that means for your supplement protocol. Included in the launch guide.
What the Data Actually Shows
The omega-3 research landscape is more nuanced than most sites reveal. PulseLine separates fact from hype: the REDUCE-IT trial showed icosapent ethyl (purified EPA) reduced major cardiovascular events by 25% at 4g/day in statin patients with elevated triglycerides. But the VITAL trial — using 1g/day EPA+DHA in the general population — showed no significant reduction in major cardiovascular events. Same nutrient family. Wildly different results. The dose, the form, and your baseline risk all matter. We break it down so you can make an informed decision — not a marketing-driven one.
Early Access Benefits
Waitlist members get exclusive access that won't be available after launch.
The Complete Omega-3 Protocol
EPA vs DHA breakdown, dosing guide, form comparison, and supplement vetting checklist — delivered on launch day.
Weekly Research Digest
One new cardiovascular study explained in plain English every week. No jargon, no spin.
Founding Member Pricing
Lock in launch-day rates on any premium guides or tools — permanently. Early supporters always pay less.
Live Q&A with Our Medical Advisor
First access to our launch-week AMA with a board-certified lipidologist. Bring your numbers.
Be the First to Know
Join the waitlist. We'll email you the moment PulseLine goes live.
3,000+ people already waiting